This white paper highlights the capabilities of a true end-to-end service, which can be used to generate whole-tissue data for enhanced histological context and a truly unbiased, reproducible approach to spatial analysis in oncology clinical trials.

Avian influenza A (H5N1) is evolving. Learn how global experts are accelerating virus detection, vaccine development, and outbreak readiness to protect those most at risk. Discover the science and strategy behind pandemic preparedness in our new eBook.

The U.S. Most Favored Nation (MFN) policy is moving from debate to enforcement with 60-day deadlines, affecting launch pricing, contracts, and global sequencing. Explore key policy insights and impacts in Herspiegel’s Policy Brief.

Oncology licensing deals are moving faster than ever, with shrinking windows and rising competition. This infographic outlines four strategies sponsors can use to accelerate readiness, boost asset value, and secure stronger deals.

Efficient language solutions can make or break clinical trials by impacting cost, timelines, and patient engagement. Download this white paper to explore best practices and strategies for reducing risk and accelerating R&D.

Transitioning from clinical stage to commercial is just the start. This paper explores how cell & gene supply chains must always evolve as a company matures.

Middlesex County, NJ is becoming a leading hub for biotech and drug development, offering talent, resources, and infrastructure to help life science companies thrive. Download the free report today to see why it’s the smart choice for your next stage of growth.

Through real world examples this e-book shows how Molecular Patient Data delivers human-centric insights to accelerate pipelines, de-risk decisions, and validate biomarkers - helping you uncover targets and move programs forward with confidence

Accelerate drug development with fast, scalable, and compliant NGS secondary analysis—turning raw sequencing data into insights with workflows for variant calling, gene expression, fusion detection, and copy number variation analysis. IQVIA Laboratories platform streamlines bioinformatics to help pharma and biotech teams identify targets, validate biomarkers, and fast-track clinical trial readiness.